Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States

BACKGROUND: Real-world data on treatment patterns among patients with ulcerative colitis (UC) initiated on ustekinumab are limited. METHODS: Adults with UC initiated on ustekinumab (index date) between 10/18/2019 and 04/31/2022 were selected from a deidentified health insurance claims database (Symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhdanava, Maryia, Zhao, Ruizhi, Manceur, Ameur M, Kachroo, Sumesh, Lefebvre, Patrick, Pilon, Dominic
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476877/
https://www.ncbi.nlm.nih.gov/pubmed/37671391
http://dx.doi.org/10.1093/crocol/otad045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476877/
https://www.ncbi.nlm.nih.gov/pubmed/37671391
http://dx.doi.org/10.1093/crocol/otad045

Ejemplares similares